Treatment selection isn't enough: Why toxicity and monitoring should be built into every algorithm

Choosing a therapy is only part of the decision. Clinicians also need to know what to monitor, what toxicities to expect, and when to adjust treatment. Living Algorithms integrate these elements directly into the pathway, helping clinicians manage patients safely at the point of care.

The moment after the decision

Most oncology tools focus on one question:

What treatment should I use?

But in practice, the next question comes immediately after:

What do I need to watch for once I start?

This is where many tools fall short.

The hidden complexity of treatment

Every therapy comes with:

• Side effects

• Monitoring requirements

• Dose adjustments

• Real-world considerations
  

These are not secondary details. They are central to patient care.

Why this matters in clinic

When you start a treatment, you're also committing to:

• Monitoring labs

• Managing toxicities

• Adjusting doses

• Deciding when to hold or continue therapy
  

These decisions often happen:

• Between visits

• Under time pressure

• With incomplete information
  

Having the right details upfront makes a difference.

What clinicians actually need

At the point of care, clinicians are thinking:

Before starting treatment

• What are the key toxicities?

• What baseline labs do I need?

• Are there specific risks for this patient?
  

During treatment

• What should I monitor?

• How often?

• What are the warning signs?
  

When problems arise

• Do I hold treatment?

• Do I reduce the dose?

• Can I restart safely?
  

Where most tools fall short

Most tools separate these steps. They provide:

• Treatment recommendations in one place

• Toxicity data somewhere else

• Monitoring guidance in another resource
  

This creates fragmentation, which means clinicians have to:

• Search multiple sources

• Piece together information

• Rely on memory for details
  

The cost of fragmentation

When information is scattered:

• Important details can be missed

• Decisions take longer

• Confidence decreases
  

This is especially true for:

• Less familiar therapies

• Later-line treatments

• Complex patients
  

Toxicity is not just a side note

Not all side effects are equal. Clinicians need to quickly understand:

• Which toxicities are most important

• How severe they can be

• How frequently they occur
  

For example: mild fatigue vs grade 3 stomatitis requiring dose modification.

These differences drive decisions.

Monitoring is often therapy-specific

Some treatments require:

• Routine labs before each cycle

• Targeted monitoring for specific risks

• Awareness of less obvious complications
  

These details are easy to miss if they're not clearly presented.

Dose modification is where decisions get difficult

Many consults are driven by complications:

• A patient is not tolerating therapy

• Labs are abnormal

• Toxicity is worsening
  

At that point, clinicians need clear guidance:

• When to hold

• When to reduce

• When to resume
  

This is not always easy to find quickly.

How Living Algorithms integrate toxicity and monitoring

Living Algorithms are designed to bring these elements together.

What that looks like in practice

Side effects in context

You can quickly review:

• Common toxicities

• Serious adverse events

• Therapy-specific risks
  

All tied to the treatment step.

Monitoring built into the pathway

Instead of separate lookups, you see:

• Baseline requirements

• Ongoing labs

• Therapy-specific monitoring
  

Dose modification guidance

When issues arise, you can review:

• When to hold treatment

• How to reduce dosing

• When it is safe to restart
  

Practical clinical detail

Information is structured to support decisions:

• Clear thresholds

• Actionable steps

• Real-world considerations
  

From treatment selection to patient management

Choosing a therapy is just the beginning. Managing that therapy is where most clinical decisions happen. Tools should support both.

Supporting safer care

Having toxicity and monitoring integrated helps to:

• Reduce errors

• Improve patient counseling

• Anticipate complications

• Increase confidence in decisions
  

A more complete decision tool

A useful oncology tool should answer:

• What should I give?

• What should I watch for?

• What do I do if something goes wrong?
  

If it only answers the first question, it's incomplete.

Bottom line

Treatment selection is not enough. Clinicians need tools that support the full patient journey, from choosing a therapy to managing its effects.

Living Algorithms integrate toxicity, monitoring and dose adjustments directly into the pathway, helping clinicians deliver safer, more effective care.

Try it with your next patient

The next time you start a treatment, ask: do I have everything I need to manage this therapy?

If not, the tool is missing a critical piece.

This is where integrated decision support makes the difference.